Skip to main content
    L

    LeMaitre Vascular Inc (LMAT)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $80.89
    -2.60 (-3.11%)

    Market Cap: $1.91B

    Last updated: Nov 06, 2026 at 4:10 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(27/40)
    Avg Surprise
    +55.32%

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.73
    Range$0.69 - $0.75
    8 analysts
    Revenue Consensus
    $71M
    Range$70M - $72M
    8 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.73$0.69 - $0.75--8--
    Sep 26
    Reported Nov 4
    		$0.65$0.69$0.68 - $0.69-5.80%Miss8
    0
    8
    30d
    		-13.3%
    Jun 26
    Reported Aug 4
    		$0.74$0.81$0.79 - $0.82-8.64%Miss9
    7
    0
    30d
    		+23.3%
    Mar 26
    Reported May 5
    		$0.68$0.66$0.64 - $0.68+3.03%Beat9
    6
    0
    30d
    		+41.7%
    Dec 25
    Reported Feb 25
    		$0.68$0.66$0.63 - $0.68+3.03%Beat10
    1
    0
    30d
    		+38.8%
    Sep 25
    Reported Nov 6
    		$0.75$0.56$0.54 - $0.58+33.93%Beat8
    No revisions (30d)
    		+53.1%
    Jun 25
    Reported Aug 5
    		$0.60$0.57$0.55 - $0.58+5.26%Beat9
    1
    4
    30d
    		+15.4%
    Mar 25
    Reported May 1
    		$0.48$0.50$0.48 - $0.52-4.00%Miss9
    1
    1
    30d
    		+9.1%
    Dec 24
    Reported Feb 27
    		$0.49$0.49$0.47 - $0.52+0.00%Beat9
    5
    0
    30d
    		+28.9%
    Sep 24
    Reported Oct 31
    		$0.49$0.43$0.42 - $0.45+13.95%Beat10
    No revisions (30d)
    		+48.5%
    Jun 24
    Reported Aug 1
    		$0.52$0.47$0.45 - $0.49+10.64%Beat9
    No revisions (30d)
    		+40.5%
    Mar 24
    Reported May 2
    		$0.44$0.39$0.37 - $0.40+12.82%Beat8
    No revisions (30d)
    		+63.0%
    Dec 23
    Reported Feb 27
    		$0.38$0.36$0.34 - $0.37+5.56%Beat9
    1
    0
    30d
    		+52.0%

    Dividends

    Next ex-dividend: Nov 19, 2026

    Dividend Metrics

    Forward Yield1.24%
    Forward Annual Dividend$1.00
    Payout Ratio28.51%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+16.96%
    5Y CAGR+16.05%
    LMAT dividend history and ex-dividend datesRun LMAT in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio29.41EV/EBITDA23.36x
    Price/FCF27.61xFCF Yield3.62%
    Profitability
    Profit Margin25.00%Operating Margin29.00%
    ROE16.80%ROIC9.47%
    Financial Health
    Debt/Equity0.39xInterest Coverage14.15x
    Current Ratio14.60xQuick Ratio12.54x
    Trading Statistics
    Beta0.49Avg Volume299.51K
    52-Week High$117.3752-Week Low$78.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$83.13
    SMA 20$83.08
    SMA 50$81.48
    SMA 200$94.08
    EMA 10$82.97
    EMA 20$82.76
    EMA 50$83.26
    EMA 200$89.16

    MACD

    Line: 0.30Signal: 0.43Hist: -0.13

    ADX

    ADX: 15.6+DI: 24.3-DI: 17.7

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down16.0
    PSAR$89.23

    Bollinger Bands

    Upper Band$86.78
    Lower Band$79.38
    %B Position890%(Upper)
    Band Width0.20

    RSI (14-Day)

    Neutral
    46.5

    Momentum Oscillators

    Stoch %K44.6
    Stoch %D42.6
    Williams %R-89.7
    ROC (10d)-4.2%
    Momentum-3.56
    CCI (20d)-110.9
    MFI (14d)34.9

    Volatility Measures

    ATR (14d)$3.08(3.8%)
    StdDev (20d)1.85
    Hist Vol49.5%(High)

    Volume Flow

    VWAP$81.14
    OBV4.3M
    AD Line-27.5M
    CMF (20d)-0.107

    Volume Metrics

    Avg Vol (20d)309.5K
    Vol Ratio1.1x
    VWMA (20d)$83.10

    Pivot Points

    R3$91.31
    R2$88.64
    R1$86.06
    Pivot Point$83.40
    S1$80.82
    S2$78.15
    S3$75.58

    Advanced Oscillators

    TSI3.26
    Ultimate Osc48.3
    KST30.77

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$67.97M$70.38M$66.55M$64.45M$61.05M$64.23M$59.87M$55.72M$54.82M$55.85M$53.48M$48.88M
    Cost of Revenue$19.27M$19.62M$18.16M$18.26M$15.09M$19.26M$18.45M$17.13M$17.64M$17.38M$16.81M$15.62M
    Gross Profit$48.70M$50.76M$48.40M$46.19M$45.95M$44.97M$41.42M$38.59M$37.18M$38.47M$36.66M$33.27M
    Operating Expenses$31.01M$30.36M$30.62M$27.36M$25.64M$28.83M$28.79M$25.74M$24.03M$24.09M$24.79M$23.06M
    R&D$4.42M$4.85M$4.06M$3.53M$2.97M$3.54M$4.09M$3.62M$3.66M$4.28M$4.09M$4.35M
    SG&A$12.08M$11.11M$12.05M$10.39M$10.75M$10.40M$10.49M$9.49M$8.93M$8.82M$9.01M$8.44M
    Operating Income$17.70M$20.40M$17.77M$18.83M$20.31M$16.14M$12.63M$12.85M$13.15M$14.38M$11.87M$10.21M
    Interest Income$3.37M$3.39M$3.32M$3.35M$3.86M$2.98M$2.90M$1.61M$1.20M$1.14M$1.00M$992,000
    Interest Expense$1.30M$1.30M$1.30M$1.30M$1.30M$1.30M$1.29M$205,000$0$0$0$0
    Income Before Tax$19.67M$22.19M$19.67M$20.30M$22.57M$18.07M$14.24M$14.02M$14.55M$15.51M$12.80M$11.31M
    Income Tax Expense$4.65M$5.14M$3.99M$4.72M$5.21M$4.29M$3.23M$2.84M$3.41M$3.68M$2.91M$2.85M
    Net Income$15.02M$17.05M$15.68M$15.58M$17.36M$13.78M$11.01M$11.18M$11.14M$11.83M$9.89M$8.46M
    EBITDA$20.72M$22.99M$20.49M$21.08M$22.84M$19.26M$15.39M$15.09M$15.78M$16.75M$14.18M$12.76M
    EBIT$17.61M$20.11M$17.65M$18.25M$20.01M$16.39M$12.63M$12.62M$13.35M$14.37M$11.80M$10.32M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LMAT

    Government Contracts

    Gov Obligations (TTM)
    $202411
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    N/A
    Active Awards
    16
    New Awards (TTM)
    12
    Avg Remaining Term
    1.9 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24826P0019Department of Veterans AffairsDepartment of Veterans Affairs$31985Oct 3, 2025
    36C26126P0065Department of Veterans AffairsDepartment of Veterans Affairs$23579Oct 11, 2025
    36C25026P0461Department of Veterans AffairsDepartment of Veterans Affairs$23457Mar 2, 2026
    36C24526P0425Department of Veterans AffairsDepartment of Veterans Affairs$15844May 21, 2026
    36C25026P0434Department of Veterans AffairsDepartment of Veterans Affairs$14544Feb 27, 2026
    36C25626P0187Department of Veterans AffairsDepartment of Veterans Affairs$12049Nov 19, 2025
    36C24525P0822Department of Veterans AffairsDepartment of Veterans Affairs$11899Aug 19, 2025
    36C26226P1368Department of Veterans AffairsDepartment of Veterans Affairs$11744Jul 29, 2026
    36C24825P2010Department of Veterans AffairsDepartment of Veterans Affairs$11554Sep 5, 2025
    36C24825P1973Department of Veterans AffairsDepartment of Veterans Affairs$11554Sep 4, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Wells Fargo cuts LeMaitre Vascular stock price target on margin miss

    Wells Fargo has lowered its price target for LeMaitre Vascular shares from $94 to $86, maintaining an Equal Weight rating, after the company's third-quarter results showed a miss on gross and operating margins...

    Investing.com Canada•11/5/26•Bearish

    Citizens cuts LeMaitre Vascular stock price target on Q3 results

    Citizens has lowered its price target for LeMaitre Vascular (NASDAQ:LMAT) shares to $110 from $127, while maintaining a Market Outperform rating. This adjustment comes after the company's Q3 2026 results...

    Investing.com•11/5/26•Somewhat-Bearish

    LeMaitre Vascular earnings up next as investors seek Q3 rebound By Investing.com

    LeMaitre Vascular Inc. is set to report its third-quarter earnings, with analysts expecting $0.69 per share on revenue of $67.74 million...

    Investing.com•11/4/26•Neutral

    LMAT: LeMaitre Vascular Inc. filed SEC Form 8-K: Results of...

    LeMaitre Vascular Inc. reported preliminary Q3 2026 sales of $68.0 million, an 11% increase year-over-year, with EPS of $0.65. The company also announced a $100 million share repurchase authorization...

    Quantisnow•11/4/26•Somewhat-Bullish

    LeMaitre Vascular Q3 2026 Earnings Call Is Live

    LeMaitre Vascular's Q3 2026 earnings call has just started, where executives will discuss the latest financial results and answer questions from Wall Street analysts. Investors following LMAT should tune in to hear...

    TradingView•11/4/26•Neutral

    LMAT Valuation and Fair Value

    P/E
    29.4x
    Forward P/E
    27.9x
    EV/EBITDA
    23.4x
    P/FCF
    27.6x
    PEG
    2.3x
    P/B
    4.3x
    See GNG's fair value

    LMAT Profitability: Margins, ROIC and FCF

    Gross margin
    72.0%
    Operating margin
    29.0%
    Net margin
    25.0%
    ROIC
    9.5%
    ROE
    16.8%
    FCF margin
    24.9%
    FCF yield
    3.6%

    LMAT Competitors

    CompanyTicker
    GeneDx Holdings Corp.WGS
    Harmony Biosciences HoldingsHRMY
    Inspire Medical Systems IncINSP
    Replimune Group IncREPL
    Veracyte IncVCYT
    BioLife Solutions IncBLFS
    Fortrea Holdings Inc.FTRE
    Vir Biotechnology IncVIR

    Sector: Healthcare

    LMAT Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    2
    Buy
    2
    Hold
    4
    Sell
    0
    Strong Sell
    0

    LMAT Bull Case vs Bear Case

    Bull case

    • LMAT converts 24.9% of revenue into free cash flow.
    • LMAT has a 25.0% net profit margin.

    LMAT Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    3.4%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.73

    LMAT Dividend

    Forward yield
    1.2%
    Payout ratio
    28.5%
    3Y DPS growth
    17.0%
    5Y DPS growth
    16.1%
    Pay months
    Mar, Jun, Sep, Dec
    LMAT dividend history

    LMAT Earnings Date

    LMAT reports Feb 23, 2027, after the close. The date is estimated.

    LMAT Earnings Call

    The latest LMAT earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    LMAT ETF Holders

    GNG tracks 13 ETFs that hold LMAT. The largest weights:

    1. State Street SPDR S&P Health Care Equipment ETF (XHE), 1.60% of the fund
    2. iShares U.S. Medical Devices ETF (IHI), 0.24% of the fund
    3. iShares Core S&P Small-Cap ETF (IJR), 0.10% of the fund
    4. iShares Russell 2000 ETF (IWM), 0.07% of the fund
    5. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.06% of the fund
    Open the ETF Stock Exposure tool for LMAT

    See insider activity

    Frequently Asked Questions About LMAT

    When is LMAT's next ex-dividend date?

    LMAT's next ex-dividend date is Nov 19, 2026, for a declared dividend of $0.25 per share (record date Nov 19, 2026, payable Dec 3, 2026).

    When does LMAT report earnings?

    LeMaitre Vascular Inc (LMAT) is expected to report earnings on Feb 23, 2027.

    What is LMAT's current dividend yield?

    LeMaitre Vascular Inc (LMAT) has a forward dividend yield of 1.24%.

    Does LMAT pay dividends?

    Yes, LeMaitre Vascular Inc pays dividends with a forward dividend yield of 1.24%.

    What is LMAT's P/E ratio?

    LeMaitre Vascular Inc has a price-to-earnings (P/E) ratio of 29.41.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In